NCIt definition : Any substance that inhibits phosphodiesterase, an enzyme that catalyzes the breaking
of a phosphodiester bond. Usually, this refers to cyclic nucleotide phosphodiesterase,
an enzyme that breaks the phosphodiester bond in the second messenger molecules cAMP
and cGMP. Inhibition of cyclic nucleotide phosphodiesterase can be used to affect
vasodilation.;
https://www.cochrane.org/fr/CD014089/MUSKEL_quels-sont-les-benefices-et-les-risques-des-medicaments-qui-augmentent-le-flux-sanguin-vers-les 2023 United Kingdom review of literature french abstract Ratio secondary raynaud's phenomenon Increased Current Reformed Smoker, Years Unknown increased vascular flow risks and benefits Fear Score 5 Medication Placebo raynaud disease What Month is it Loss of Chromosome 5 Intensity and Distress 5 drug, nos Flow Extremities Clinical Status Ordinal Scale Outcome 5 extremities Version research report ECOG Performance Status 5 anthelmintics Severity of Symptom Score 5 No Flow Thought Score 5 raynaud phenomenon Death Related to Adverse Event Agreement Score 5 Illness Intrusiveness Rating 5 Raynaud Phenomenon Gleason Grade Group 5 risk assessment placebos Phase V Trial Regulatory Report Phosphodiesterase Inhibitor Neck Pain Score 5 phosphodiesterase 5 inhibitors Upset Score 5 albumin/globulin ratio Increase Flux GDC Therapeutic Agent Terminology